PrimeGen Biotech Corporation and Unidym, Inc. Form Alliance to Optimize Development of Induced Pluripotent Stem Cells

IRVINE, Calif. & MENLO PARK, Calif.--(BUSINESS WIRE)--PrimeGen Biotech LLC and Unidym Inc., a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), today announced a corporate alliance focused on exploring new applications for carbon nanotubes in stem cell medicine. Unidym brings to this partnership its leadership in carbon nanotube science, technology and production.

Back to news